Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5672) 5672
Publication (349) 349
Newsletter (123) 123
Book Review (41) 41
Magazine Article (23) 23
Book Chapter (20) 20
Book / eBook (12) 12
Newspaper Article (12) 12
Government Document (11) 11
Conference Proceeding (5) 5
Dissertation (4) 4
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5104) 5104
neurofibromatosis 1 - complications (3579) 3579
female (3056) 3056
male (2929) 2929
adult (2043) 2043
neurofibromatosis (1900) 1900
child (1526) 1526
index medicus (1362) 1362
adolescent (1325) 1325
middle aged (1324) 1324
child, preschool (932) 932
neurofibromatosis 1 - pathology (813) 813
neurofibromatosis 1 - diagnosis (810) 810
clinical neurology (715) 715
surgery (712) 712
magnetic resonance imaging (668) 668
infant (583) 583
pediatrics (581) 581
neurofibromatosis type 1 (579) 579
neurofibromatosis 1 - genetics (541) 541
children (525) 525
aged (514) 514
tumors (469) 469
tomography, x-ray computed (454) 454
treatment outcome (387) 387
radiography (386) 386
diagnosis, differential (377) 377
diagnosis (359) 359
retrospective studies (352) 352
neurofibromatosis 1 (351) 351
neurofibromatosis 1 - surgery (335) 335
research (318) 318
care and treatment (314) 314
follow-up studies (312) 312
nf1 (308) 308
young adult (302) 302
oncology (299) 299
neurofibromatosis 1 - diagnostic imaging (274) 274
risk factors (258) 258
mutation (252) 252
genetics & heredity (248) 248
skin neoplasms - complications (235) 235
type-1 (233) 233
medicine & public health (227) 227
management (225) 225
neurofibromatosis 2 - complications (221) 221
neurofibromatoses - complications (217) 217
neurosciences (216) 216
disease (207) 207
neurofibromatosis type-1 (206) 206
case report (196) 196
dermatology (191) 191
genetic aspects (187) 187
complications and side effects (183) 183
prognosis (175) 175
ophthalmology (173) 173
neurofibromatosis 1 - physiopathology (172) 172
pathology (172) 172
gene (167) 167
infant, newborn (165) 165
cancer (164) 164
neurofibroma (161) 161
medicine, general & internal (159) 159
case studies (158) 158
orthopedics (158) 158
pregnancy (153) 153
animals (152) 152
medicine (151) 151
neoplasms (150) 150
health aspects (149) 149
brain neoplasms - complications (144) 144
pheochromocytoma - complications (144) 144
patients (142) 142
otorhinolaryngology (139) 139
neurofibromatosis 1 - therapy (138) 138
article (136) 136
recklinghausen's disease (136) 136
analysis (134) 134
congenital, hereditary, and neonatal diseases and abnormalities (134) 134
patient (134) 134
phenotype (134) 134
vonrecklinghausen neurofibromatosis (134) 134
neurology (132) 132
abridged index medicus (125) 125
gliomas (120) 120
neurilemmoma - complications (119) 119
neurofibromatosis 1 - epidemiology (119) 119
radiology, nuclear medicine & medical imaging (117) 117
mutations (116) 116
skin neoplasms - pathology (116) 116
immunohistochemistry (115) 115
pedigree (112) 112
neurilemmoma - pathology (111) 111
age factors (110) 110
nervous system diseases (109) 109
neurosurgery (108) 108
von recklinghausen's disease (108) 108
biopsy (106) 106
fatal outcome (105) 105
genetics (104) 104
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4705) 4705
French (358) 358
German (205) 205
Japanese (168) 168
Spanish (125) 125
Italian (70) 70
Russian (57) 57
Polish (45) 45
Portuguese (19) 19
Dutch (17) 17
Hungarian (15) 15
Czech (14) 14
Romanian (14) 14
Danish (10) 10
Korean (10) 10
Serbian (7) 7
Chinese (6) 6
Croatian (6) 6
Norwegian (6) 6
Hebrew (5) 5
Turkish (5) 5
Swedish (3) 3
Bulgarian (1) 1
Finnish (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Neurofibromatosis type 1 and pregnancy complications: a population-based study
by Terry, Anna R., MD, MPH and Barker, Fred G., MD and Leffert, Lisa, MD and Bateman, Brian T., MD and Souter, Irene, MD and Plotkin, Scott R., MD, PhD
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2013, Volume 209, Issue 1, pp. 46.e1 - 46.e8
Objective The objective of the study was to determine whether vascular and other complications are more common in pregnant women with neurofibromatosis type 1... 
Obstetrics and Gynecology | intrauterine growth restriction | epidemiology | cesarean section | neurofibromatosis | preeclampsia | Intrauterine growth restriction | Epidemiology | Neurofibromatosis | Preeclampsia | Cesarean section | UNITED-STATES | ABNORMALITIES | PREVENTION | RISK | MATERNAL MORTALITY | OBSTETRICS & GYNECOLOGY | MORBIDITY | CARDIOVASCULAR-DISEASE | NF1 | LIFE | Maternal Mortality | International Classification of Diseases | Pre-Eclampsia - epidemiology | United States - epidemiology | Pregnancy Complications - etiology | Obstetric Labor, Premature - epidemiology | Humans | Cesarean Section - statistics & numerical data | Fetal Growth Retardation - epidemiology | Logistic Models | Pre-Eclampsia - etiology | Pregnancy | Neurofibromatosis 1 - complications | Hypertension, Pregnancy-Induced - epidemiology | Adult | Female | Obstetric Labor, Premature - etiology | Retrospective Studies | Hypertension, Pregnancy-Induced - etiology | Infant, Newborn | Pregnancy Complications - epidemiology | Complications and side effects | Analgesics | Pregnant women
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The spectrum of nephrocutaneous diseases and associations: Genetic causes of nephrocutaneous disease
by Wofford, Jay and Wofford, Jay and Fenves, Andrew Z and Fenves, Andrew Z and Jackson, J. Mark and Jackson, J Mark and Kimball, Alexa B and Kimball, Alexa B and Menter, Alan and Menter, Alan
Journal of the American Academy of Dermatology, ISSN 0190-9622, 02/2016, Volume 74, Issue 2, pp. 231 - 231
There are a significant number of diseases and treatment considerations of considerable importance relating to the skin and renal systems. This emphasizes the... 
genetic | nephrology | dermatology | autoimmune | genodermatoses | inflammatory | nephrocutaneous | Uterine Neoplasms - therapy | Skin Diseases - genetics | Tuberous Sclerosis - complications | Beckwith-Wiedemann Syndrome - therapy | Fabry Disease - genetics | Humans | Genetic Diseases, Inborn - genetics | von Hippel-Lindau Disease - complications | Genetic Diseases, Inborn - therapy | Beckwith-Wiedemann Syndrome - genetics | Kidney Diseases - genetics | Nail-Patella Syndrome - therapy | Neurofibromatosis 1 - therapy | Neoplastic Syndromes, Hereditary | Beckwith-Wiedemann Syndrome - complications | Leiomyomatosis - complications | Leiomyomatosis - therapy | Birt-Hogg-Dube Syndrome - complications | Turner Syndrome - complications | Turner Syndrome - therapy | Neurofibromatosis 1 - genetics | Uterine Neoplasms - genetics | von Hippel-Lindau Disease - therapy | Hamartoma Syndrome, Multiple - genetics | Skin Neoplasms - therapy | Nail-Patella Syndrome - genetics | Fabry Disease - complications | von Hippel-Lindau Disease - genetics | Hamartoma Syndrome, Multiple - complications | Birt-Hogg-Dube Syndrome - genetics | Tuberous Sclerosis - genetics | Tuberous Sclerosis - therapy | Skin Neoplasms - complications | Birt-Hogg-Dube Syndrome - therapy | Hamartoma Syndrome, Multiple - therapy | Skin Neoplasms - genetics | Neurofibromatosis 1 - complications | Uterine Neoplasms - complications | Nail-Patella Syndrome - complications | Turner Syndrome - genetics | Fabry Disease - therapy | Mutation | Leiomyomatosis - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Nonrandomized comparison of neurofibromatosis type 1 and non–neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low‐grade glioma: A report from the Children's Oncology Group
by Ater, Joann L and Xia, Caihong and Mazewski, Claire M and Booth, Timothy N and Freyer, David R and Packer, Roger J and Sposto, Richard and Vezina, Gilbert and Pollack, Ian F
Cancer, ISSN 0008-543X, 06/2016, Volume 122, Issue 12, pp. 1928 - 1936
Children with neurofibromatosis type 1 who are treated for low‐grade gliomas tolerate carboplatin and vincristine well and have tumor response rates and... 
vincristine | neurofibromatosis 1 | carboplatin | childhood low‐grade glioma | pilocytic astrocytoma | childhood low-grade glioma | MULTICENTER | PHASE-II | OPTIC PATHWAY | TUMORS | CHEMOTHERAPY | ONCOLOGY | RECURRENT | WEEKLY VINBLASTINE | Procarbazine - administration & dosage | Humans | Carboplatin - administration & dosage | Child, Preschool | Male | Brain Neoplasms - complications | Brain Neoplasms - drug therapy | Glioma - complications | Thioguanine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neurofibromatosis 1 - drug therapy | Neurofibromatosis 1 - complications | Vincristine - administration & dosage | Female | Child | Glioma - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1
by Prada, Carlos E., MD and Hufnagel, Robert B., MD, PhD and Hummel, Trent R., MD and Lovell, Anne M., MSN, CNP and Hopkin, Robert J., MD and Saal, Howard M., MD and Schorry, Elizabeth K., MD
Journal of Pediatrics, The, ISSN 0022-3476, 2015, Volume 167, Issue 4, pp. 851 - 856.e1
Objective To evaluate the utility of screening brain/orbital magnetic resonance imaging (MRI) in a large population of children with neurofibromatosis type 1... 
Pediatrics | PEDIATRICS | OUTCOMES | NATURAL-HISTORY | TUMORS | Optic Nerve Neoplasms - complications | Comorbidity | Humans | Optic Nerve Glioma - diagnosis | Child, Preschool | Optic Nerve Glioma - complications | Infant | Male | Neurofibromatosis 1 - diagnosis | Disease Progression | Vision Disorders - complications | Magnetic Resonance Imaging | Vision Disorders - diagnosis | Optic Nerve Neoplasms - diagnosis | Neurofibromatosis 1 - complications | Brain - pathology | Female | Retrospective Studies | Child | Usage | Magnetic resonance imaging | Gliomas | Neurofibromatosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Neurofibromatosis type 1 and autism spectrum disorder
by Garg, Shruti and Green, Jonathan and Leadbitter, Kathy and Emsley, Richard and Lehtonen, Annukka and Evans, Gareth and Huson, Susan M
Pediatrics, ISSN 0031-4005, 12/2013, Volume 132, Issue 6, pp. e1642 - e1648
OBJECTIVE: To determine the prevalence of autism spectrum disorder (ASD) in Neurofibromatosis Type 1 (NF1). METHODS: Second-phase population-based... 
Autism | Population | Neurofibromatosis type 1 | Epidemiology | DIAGNOSIS | INFORMATION | PSYCHIATRIC COMORBIDITY | PREVALENCE | autism | population | CHILDREN | epidemiology | UK | MOUSE MODEL | neurofibromatosis type 1 | PEDIATRICS | DEFICITS | Child Development Disorders, Pervasive - epidemiology | Prevalence | Prospective Studies | Humans | Child, Preschool | England | Child Development Disorders, Pervasive - etiology | Logistic Models | Male | Chi-Square Distribution | Adolescent | Child Development Disorders, Pervasive - diagnosis | Neurofibromatosis 1 - complications | Female | Registries | Psychological Tests | Child | Complications and side effects | Genetic aspects | Research | Neurofibromatosis | Risk factors | Pervasive developmental disorders | Pediatrics | Genetic disorders | Socioeconomic factors | Childrens health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
by Robertson, Kent A, Dr and Nalepa, Grzegorz, MD and Yang, Feng-Chun, MD and Bowers, Daniel C, MD and Ho, Chang Y, MD and Hutchins, Gary D, Prof and Croop, James M, Prof and Vik, Terry A, MD and Denne, Scott C, Prof and Parada, Luis F, Prof and Hingtgen, Cynthia M, MD and Walsh, Laurence E, MD and Yu, Menggang, PhD and Pradhan, Kamnesh R, MD and Edwards-Brown, Mary K, Prof and Cohen, Mervyn D, Prof and Fletcher, James W, Prof and Travers, Jeffrey B, Prof and Staser, Karl W, PhD and Lee, Melissa W, BS and Sherman, Marcie R, BS and Davis, Cynthia J, RN and Miller, Lucy C, RN and Ingram, David A, Prof and Clapp, D Wade, Prof
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 12, pp. 1218 - 1224
Summary Background Plexiform neurofibromas are slow-growing chemoradiotherapy-resistant tumours arising in patients with neurofibromatosis type 1 (NF1).... 
Hematology, Oncology and Palliative Medicine | MICROENVIRONMENT | ONCOLOGY | MRI | PERFORMANCE | MAST-CELLS | I TRIAL | NF1 | NF1(+/-) | CHILDHOOD | TUMORS | CHILDREN | Neurofibroma, Plexiform - pathology | Humans | Middle Aged | Child, Preschool | Male | Antineoplastic Agents - therapeutic use | Piperazines - therapeutic use | Neurofibroma, Plexiform - drug therapy | Imatinib Mesylate | Young Adult | Magnetic Resonance Imaging | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Neurofibromatosis 1 - complications | Adult | Female | Benzamides | Child | Neurofibroma, Plexiform - complications | Clinical trials | Medical colleges | Care and treatment | Neurosciences | Neurofibromatosis | Children's hospitals
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The pregnancy in neurofibromatosis 1: A retrospective register‐based total population study
by Leppävirta, Jussi and Kallionpää, Roope A and Uusitalo, Elina and Vahlberg, Tero and Pöyhönen, Minna and Timonen, Susanna and Peltonen, Juha and Peltonen, Sirkku
American Journal of Medical Genetics Part A, ISSN 1552-4825, 10/2017, Volume 173, Issue 10, pp. 2641 - 2648
The objective of this retrospective total population study was to form a view of the pregnancies of the patients with neurofibromatosis type 1 (NF1). A cohort... 
neurofibromatosis type 1 | pregnancy complication | pregnancy duration | delivery complications | QUALITY | GENETICS & HEREDITY | PREVALENCE | TYPE-1 | EPIDEMIOLOGY | CHILDREN | Pregnancy Complications - etiology | Humans | Cesarean Section - statistics & numerical data | Male | Incidence | Pregnancy | Registries - statistics & numerical data | Neurofibromatosis 1 - complications | Adult | Female | Retrospective Studies | Child | Finland - epidemiology | Pregnancy Complications - epidemiology | Pregnant women | Neurofibromatosis | Placenta | Fetuses | Pregnancy complications | Medical records | Population studies | Pre-eclampsia | Health risk assessment | Recklinghausen's disease | Mothers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A 63-Year-Old Woman With Neurofibromatosis Type 1 and Pulmonary Hypertension With Worsening Hypoxemia
by Chaddha, Udit and Puscas, Ioan and Prosper, Ashley and Ganesh, Sivagini and Yaghmour, Bassam
Chest, ISSN 0012-3692, 10/2017, Volume 152, Issue 4, pp. e89 - e93
A 63-year-old woman with a history of neurofibromatosis type-1 (NF-1) and pulmonary arterial hypertension (PAH) thought to be secondary to the NF-1 presented... 
CAPILLARY HEMANGIOMATOSIS | VENOOCCLUSIVE DISEASE | RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Hemangioma, Capillary - complications | Diagnosis, Differential | Hypertension, Pulmonary - diagnosis | Echocardiography | Hemangioma, Capillary - therapy | Humans | Hypoxia - etiology | Middle Aged | Tomography, X-Ray Computed | Lung Neoplasms - therapy | Hypoxia - diagnosis | Magnetic Resonance Imaging, Cine | Hypoxia - therapy | Oxygen Inhalation Therapy | Hypertension, Pulmonary - therapy | Lung Neoplasms - complications | Biopsy | Pulmonary Wedge Pressure - physiology | Hemangioma, Capillary - diagnosis | Neurofibromatosis 1 - complications | Female | Lung Neoplasms - diagnosis | Hypertension, Pulmonary - complications | Complications and side effects | CT imaging | Usage | Aged women | Neurofibromatosis | Hypoxia | Health aspects | Risk factors | Pulmonary hypertension
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Visual Loss in Orbitofacial Neurofibromatosis Type 1
by Oystreck, Darren T., MMedSci, OC(C) and Morales, Jose, MD and Chaudhry, Imtiaz, MD, PhD and Alorainy, Ibrahim A., MD and Elkhamary, Sahar M., MD and Pasha, Taha M.U., MBBS and Bosley, Thomas M., MD
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 10, pp. 2168 - 2173
Purpose On occasion, neurofibromas in neurofibromatosis type 1 may be present on the lid, brow, or face of an infant or child, a circumstance commonly referred... 
Ophthalmology | TOMOGRAPHY | MANAGEMENT | NF1 | DYSPLASIA | TUMOR | OPHTHALMOLOGY | OPTIC PATHWAY GLIOMAS | CLASSIFICATION | SCREENING CHILDREN | ORBITOTEMPORAL NEUROFIBROMATOSIS | Optic Nerve Neoplasms - complications | Refractive Errors - complications | Humans | Middle Aged | Child, Preschool | Male | Retinal Detachment - complications | Young Adult | Adult | Female | Retrospective Studies | Visual Pathways - pathology | Amblyopia - complications | Child | Orbital Neoplasms - complications | Refractive Errors - diagnosis | Orbital Neoplasms - pathology | Optic Nerve Glioma - complications | Glaucoma - complications | Glaucoma - diagnosis | Visual Acuity | Amblyopia - diagnosis | Magnetic Resonance Imaging | Optic Nerve Glioma - pathology | Vision Disorders - diagnosis | Neurofibromatosis 1 - pathology | Optic Nerve Neoplasms - pathology | Adolescent | Neurofibromatosis 1 - complications | Facial Neoplasms - complications | Facial Neoplasms - pathology | Vision Disorders - etiology | Neurofibromatosis | Universities and colleges
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1
by Stewart, Douglas R and Sloan, Jennifer L and Yao, Lawrence and Mannes, Andrew J and Moshyedi, Armin and Richard Lee, Chyi-Chia and Sciot, Raf and De Smet, Luc and Mautner, Victor-Felix and Legius, Eric
Journal of Medical Genetics, ISSN 0022-2593, 08/2010, Volume 47, Issue 8, pp. 525 - 532
BackgroundGlomus tumours are benign painful tumours of the glomus body, a thermoregulatory shunt in the digits. Glomus tumours of the fingers and toes are... 
HAND | GENETICS & HEREDITY | Glomus Tumor - pathology | Demography | Fingers - diagnostic imaging | Humans | Middle Aged | Male | Fingers - pathology | Glomus Tumor - complications | Nails - pathology | Radiography | Toes - diagnostic imaging | Magnetic Resonance Imaging | Belgium | Glomus Tumor - diagnosis | Neurofibromatosis 1 - complications | Adult | Female | Toes - abnormalities | Toes - pathology | Fingers - abnormalities | Child | Glomus Tumor - therapy | Complications and side effects | Care and treatment | Neurofibromatosis | Analysis | Chemical senses | Genetic aspects | Research | Carotid body | Diseases | Neurofibromatosis type 1 | Glomus body | Fingertip | Glomus tumor | Complex regional pain syndrome
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Rectal carcinoma and multiple gastrointestinal stromal tumors (GIST) of the small intestine in a patient with neurofibromatosis type 1: A case report
by Hakozaki, Yuhei and Sameshima, Shinichi and Tatsuoka, Teppei and Okuyama, Takashi and Yamagata, Yukinori and Noie, Tamaki and Oya, Masatoshi and Fujii, Akiko and Ueda, Yoshihiko and Shimura, Chieko and Katagiri, Kazumoto
World Journal of Surgical Oncology, ISSN 1477-7819, 08/2017, Volume 15, Issue 1, p. 160
Background: Neurofibromatosis type 1 (NF1) is an autosomally dominant inherited disorder characterized by multiple pigmented skin spots (cafE-au-lait spots)... 
SURGERY | NF1 | RECKLINGHAUSENS DISEASE | GENE | ONCOLOGY | MANIFESTATIONS | Adenocarcinoma - pathology | Jejunum - pathology | Humans | Tomography, X-Ray Computed - methods | Neurofibromatosis 1 - therapy | Duodenal Neoplasms - complications | Neurofibroma - pathology | Neoplasms, Multiple Primary - therapy | Laparoscopy - methods | Chemotherapy, Adjuvant - adverse effects | Contrast Media - administration & dosage | Skin Neoplasms - diagnosis | Endoscopy, Gastrointestinal - methods | Occult Blood | Rectal Neoplasms - pathology | Duodenum - diagnostic imaging | Duodenal Neoplasms - pathology | Digestive System Surgical Procedures - methods | Skin Neoplasms - therapy | Rectal Neoplasms - complications | Neurofibromatosis 1 - diagnosis | Lymphatic Metastasis | Withholding Treatment | Intestinal Neoplasms - pathology | Intestinal Neoplasms - therapy | Adenocarcinoma - diagnosis | Gastrointestinal Stromal Tumors - therapy | Adenocarcinoma - therapy | Neurofibromatosis 1 - complications | Neoplasms, Multiple Primary - complications | Intestinal Neoplasms - complications | Rectal Neoplasms - diagnosis | Prognosis | Intestine, Small - pathology | Neurofibroma - complications | Diarrhea - chemically induced | Gastrointestinal Stromal Tumors - diagnosis | Gastrointestinal Stromal Tumors - pathology | Female | Intestinal Neoplasms - diagnosis | Neurofibroma - diagnosis | Neoplasms, Multiple Primary - diagnosis | Skin Neoplasms - pathology | Jejunum - surgery | Duodenal Neoplasms - therapy | Duodenal Neoplasms - diagnosis | Neoplasms, Multiple Primary - pathology | Rectal Neoplasms - therapy | Adenocarcinoma - complications | Skin Neoplasms - complications | Neurofibroma - therapy | Neurofibromatosis 1 - pathology | Duodenum - surgery | Intestine, Small - surgery | Biopsy | Chemotherapy, Adjuvant - methods | Duodenum - pathology | Intestine, Small - diagnostic imaging | Gastrointestinal Stromal Tumors - complications | Aged | Neoplasm Staging | Jejunum - diagnostic imaging | Case studies | Complications and side effects | Care and treatment | Neurofibromatosis | Colorectal cancer | Diagnosis | Stomach cancer | Risk factors | Adenocarcinoma | Colorectal carcinoma | Nervous system | Small intestine | Lymph nodes | Metastases | Proteins | Endoscopes | Jejunum | Colonoscopy | Surgery | Spots | Population | Endoscopy | Colon | Digestive tract | CD34 antigen | Antigens | Lymphatic system | Risk groups | Duodenum | Histology | Laparoscopy | Recklinghausen's disease | Patients | Hereditary diseases | Abdomen | Nodules | Ostomy | Rectum | Skin | Mutation | Cancer | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Unusual complication of neurofibromatosis
by Chatzis, Andrew and Kanakis, Meletios and Lioulias, Achilleas and Mitropoulos, Fotios
European Journal of Cardio-Thoracic Surgery, ISSN 1010-7940, 11/2014, Volume 46, Issue 5, pp. 921 - 921
Trachea | Neurofibroma | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RESPIRATORY SYSTEM | Humans | Male | Kyphosis - diagnostic imaging | Scoliosis - pathology | Radiography | Scoliosis - surgery | Trachea - pathology | Neurofibromatosis 1 - pathology | Kyphosis - surgery | Adolescent | Neurofibromatosis 1 - complications | Kyphosis - pathology | Scoliosis - diagnostic imaging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1
by Prada, Carlos E., MD and Rangwala, Fatima A., MD and Martin, Lisa J., PhD and Lovell, Anne M., MSN, CNP and Saal, Howard M., MD and Schorry, Elizabeth K., MD and Hopkin, Robert J., MD
Journal of Pediatrics, The, ISSN 0022-3476, 2012, Volume 160, Issue 3, pp. 461 - 467
Objective To characterize morbidity, mortality, and surgical outcomes in pediatric patients with symptomatic plexiform neurofibromas (PNFs). Study design We... 
Pediatrics | POPULATION | MANAGEMENT | BENIGN | MRI | NF1 | PHENOTYPE | FOLLOW-UP | PEDIATRICS | EXPERIENCE | NERVE SHEATH TUMORS | CHILDREN | Neurofibroma, Plexiform - pathology | Humans | Child, Preschool | Infant | Male | Neurofibroma, Plexiform - mortality | Neurofibromatosis 1 - mortality | Neurofibroma, Plexiform - surgery | Nerve Sheath Neoplasms - complications | Adolescent | Neurofibromatosis 1 - complications | Female | Peripheral Nervous System Neoplasms - complications | Child | Neurofibroma, Plexiform - complications | Neurofibromatosis | Patient outcomes | Mortality | Children | Health aspects | Morbidity
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1
by WALSH, KARIN S and VÉLEZ, JORGE I and KARDEL, PETER G and IMAS, DANIEL M and MUENKE, MAXIMILIAN and PACKER, ROGER J and CASTELLANOS, FRANCISCO X and ACOSTA, MARIA T
Developmental Medicine & Child Neurology, ISSN 0012-1622, 02/2013, Volume 55, Issue 2, pp. 131 - 138
Aim  Difficulties in neurocognition and social interaction are the most prominent causes of morbidity and long‐term disability in children with... 
ADHD | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | GENE | SUBTYPES | BEHAVIOR | SUSCEPTIBILITY | PEDIATRICS | ASSOCIATION | CLINICAL NEUROLOGY | COGNITIVE DEFICITS | CHILDREN | Child Development Disorders, Pervasive - epidemiology | Prevalence | Cross-Sectional Studies | Neurofibromatosis 1 - epidemiology | Humans | Attention | Child, Preschool | Male | Cognition | Neurofibromatosis 1 - psychology | Neuropsychological Tests | Child Development Disorders, Pervasive - complications | Social Behavior | Adolescent | Child Development Disorders, Pervasive - diagnosis | Neurofibromatosis 1 - complications | Attention Deficit Disorder with Hyperactivity - complications | Female | Retrospective Studies | Attention Deficit Disorder with Hyperactivity - diagnosis | Child | Attention Deficit Disorder with Hyperactivity - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors
by Wang, Shiyang and Liechty, Benjamin and Patel, Seema and Weber, Jeffrey S and Hollmann, Travis J and Snuderl, Matija and Karajannis, Matthias A
Journal of Neuro-Oncology, ISSN 0167-594X, 05/2018, Volume 138, Issue 1, pp. 183 - 190
Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) or its ligand (PD-L1) have been shown to be effective in treating patients with a variety... 
Tumor infiltrating lymphocytes | Programmed death-ligand 1 | Neurofibromatosis type 1 | Neurofibromatosis type 2 | Meningioma | Neurofibroma | Schwannoma | B7-H1 EXPRESSION | GLIOMA | CANCER | CLINICAL NEUROLOGY | INHIBITION | ONCOLOGY | GROWTH-FACTOR | VESTIBULAR SCHWANNOMAS | PD-L1 ANTIBODIES | CELL | TUMORIGENESIS | Neurofibromatosis 2 - complications | Central Nervous System Neoplasms - metabolism | Meningioma - metabolism | Humans | Middle Aged | Male | Meningioma - complications | Neurilemmoma - pathology | Antigens, CD - metabolism | Young Adult | Meningioma - pathology | B7-H1 Antigen - metabolism | Central Nervous System Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Neurilemmoma - metabolism | Adolescent | Neurofibromatosis 1 - complications | Neurilemmoma - complications | Adult | Female | Central Nervous System Neoplasms - complications | Child | Immunohistochemistry | Lymphocytes | Cell death | Immunotherapy | Neurofibromatosis | Formaldehyde | Cancer | Parkinson's disease | PD-1 protein | Neurodegenerative diseases | Tumor cells | CD8 antigen | Clinical trials | Neurofibromin 2 | CD3 antigen | Paraffin | Recklinghausen's disease | Immunity (cell-mediated) | Immune checkpoint | CD20 antigen | Ligands | Skin | Movement disorders | Apoptosis | Tumors | meningioma | tumor infiltrating lymphocytes | neurofibromatosis type 1 | neurofibromatosis type 2 | neurofibroma | programmed death-ligand 1 | schwannoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future
by Reilly, Karlyne M and Kim, AeRang and Blakely, Jaishri and Ferner, Rosalie E and Gutmann, David H and Legius, Eric and Miettinen, Markku M and Randall, R Lor and Ratner, Nancy and Jumbé, N.L and Bakker, Annette and Viskochil, David and Widemann, Brigitte C and Stewart, Douglas R
Journal of the National Cancer Institute, ISSN 0027-8874, 08/2017, Volume 109, Issue 8, p. djx124
Malignant peripheral nerve sheath tumor (MPNST) is an aggressive soft tissue sarcoma for which the only effective therapy is surgery. In 2016, an international... 
NF1 | PHASE-II | ONCOLOGY | NERVE SHEATH TUMORS | IMATINIB | Therapies, Investigational - methods | Practice Guidelines as Topic - standards | Humans | Nerve Sheath Neoplasms - diagnosis | Biomedical Research - trends | Neurofibromatosis 1 - diagnosis | Consensus | Neurofibromatosis 1 - therapy | Neurilemmoma - therapy | Nerve Sheath Neoplasms - complications | Therapies, Investigational - trends | Neurofibromatosis 1 - complications | Neurilemmoma - complications | Nerve Sheath Neoplasms - therapy | Neurilemmoma - diagnosis | Neurofibromatosis | Risk factors | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights